Indu Kheterpal1, Peter Scherp1, Lauren Kelley1, Zhong Wang2, William Johnson3, David Ribnicky4, William T Cefalu5. 1. Protein Structural Biology and Proteomics and Metabolomics Core Facility, Pennington Biomedical Research Center, Louisiana State University System, Louisiana, USA. 2. Diabetes and Nutrition Laboratory, Pennington Biomedical Research Center, Louisiana State University System, Louisiana, USA. 3. Biostatistics and Data Management, Pennington Biomedical Research Center, Louisiana State University System, Louisiana, USA. 4. Department of Plant Biology and Pathology, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA. 5. Diabetes and Nutrition Laboratory, Pennington Biomedical Research Center, Louisiana State University System, Louisiana, USA. Electronic address: William.Cefalu@pbrc.edu.
Abstract
OBJECTIVES: A botanical extract from Artemisia dracunculus L., termed PMI 5011, has been shown to improve insulin sensitivity by increasing cellular insulin signaling in in vitro and in vivo studies. These studies suggest that PMI 5011 effects changes in phosphorylation levels of proteins involved in insulin signaling. The aim of this study was to explore the effects of this promising botanical extract on the human skeletal muscle phosphoproteome, by evaluating changes in site-specific protein phosphorylation levels in primary skeletal muscle cultures from obese, insulin-resistant individuals stimulated with and without insulin. METHODS: Insulin resistance is a condition in which a normal or elevated insulin level results in an abnormal biologic response, e.g., glucose uptake. Using isobaric tagging for relative and absolute quantification (iTRAQ™) followed by phosphopeptide enrichment and liquid chromatography-tandem mass spectrometry, 125 unique phosphopeptides and 159 unique phosphorylation sites from 80 unique proteins were identified and quantified. RESULTS: Insulin stimulation of primary cultured muscle cells from insulin-resistant individuals resulted in minimal increase in phosphorylation, demonstrating impaired insulin action in this condition. Treatment with PMI 5011 resulted in significant up-regulation of 35 phosphopeptides that were mapped to proteins participating in the regulation of transcription, translation, actin cytoskeleton signaling, caveolae translocation, and translocation of glucose transporter 4. These data further showed that PMI 5011 increased phosphorylation levels of specific amino acids in proteins in the insulin-resistant state that are normally phosphorylated by insulin (thus, increasing cellular insulin signaling) and PMI 5011 also increased the abundance of phosphorylation sites of proteins regulating anti-apoptotic effects. CONCLUSION: This phosphoproteomics analysis demonstrated conclusively that PMI 5011 effects changes in phosphorylation levels of proteins and identified novel pathways by which PMI 5011 exerts its insulin-sensitizing effects in skeletal muscle.
OBJECTIVES: A botanical extract from Artemisia dracunculus L., termed PMI 5011, has been shown to improve insulin sensitivity by increasing cellular insulin signaling in in vitro and in vivo studies. These studies suggest that PMI 5011 effects changes in phosphorylation levels of proteins involved in insulin signaling. The aim of this study was to explore the effects of this promising botanical extract on the human skeletal muscle phosphoproteome, by evaluating changes in site-specific protein phosphorylation levels in primary skeletal muscle cultures from obese, insulin-resistant individuals stimulated with and without insulin. METHODS:Insulin resistance is a condition in which a normal or elevated insulin level results in an abnormal biologic response, e.g., glucose uptake. Using isobaric tagging for relative and absolute quantification (iTRAQ™) followed by phosphopeptide enrichment and liquid chromatography-tandem mass spectrometry, 125 unique phosphopeptides and 159 unique phosphorylation sites from 80 unique proteins were identified and quantified. RESULTS:Insulin stimulation of primary cultured muscle cells from insulin-resistant individuals resulted in minimal increase in phosphorylation, demonstrating impaired insulin action in this condition. Treatment with PMI 5011 resulted in significant up-regulation of 35 phosphopeptides that were mapped to proteins participating in the regulation of transcription, translation, actin cytoskeleton signaling, caveolae translocation, and translocation of glucose transporter 4. These data further showed that PMI 5011 increased phosphorylation levels of specific amino acids in proteins in the insulin-resistant state that are normally phosphorylated by insulin (thus, increasing cellular insulin signaling) and PMI 5011 also increased the abundance of phosphorylation sites of proteins regulating anti-apoptotic effects. CONCLUSION: This phosphoproteomics analysis demonstrated conclusively that PMI 5011 effects changes in phosphorylation levels of proteins and identified novel pathways by which PMI 5011 exerts its insulin-sensitizing effects in skeletal muscle.
Authors: Sithes Logendra; David M Ribnicky; Hui Yang; Alexander Poulev; Jun Ma; Edward J Kennelly; Ilya Raskin Journal: Phytochemistry Date: 2006-06-27 Impact factor: 4.072
Authors: Yongmei Yu; Charlotte Simmler; Peter Kuhn; Alexander Poulev; Ilya Raskin; David Ribnicky; Z Elizabeth Floyd; Guido F Pauli Journal: J Nat Prod Date: 2019-12-09 Impact factor: 4.050
Authors: Yongmei Yu; Tamra M Mendoza; David M Ribnicky; Alexander Poulev; Robert C Noland; Randall L Mynatt; Ilya Raskin; William T Cefalu; Z Elizabeth Floyd Journal: Mol Nutr Food Res Date: 2018-04-03 Impact factor: 5.914
Authors: B Vandanmagsar; Y Yu; C Simmler; T N Dang; P Kuhn; A Poulev; D M Ribnicky; G F Pauli; Z E Floyd Journal: Biomed Pharmacother Date: 2021-09-23 Impact factor: 6.529
Authors: Scott Fuller; Yongmei Yu; Timothy D Allerton; Tamra Mendoza; David M Ribnicky; Z Elizabeth Floyd Journal: Nutrients Date: 2020-07-27 Impact factor: 5.717
Authors: Jun Wang; Adelaida Esteban Fernández; Simoni Tiano; Jing Huang; Elizabeth Floyd; Alexander Poulev; David Ribnicky; Giulio M Pasinetti Journal: Oxid Med Cell Longev Date: 2018-05-13 Impact factor: 6.543
Authors: Scott Fuller; Yongmei Yu; Tamra Mendoza; David M Ribnicky; William T Cefalu; Z Elizabeth Floyd Journal: Biol Sex Differ Date: 2018-09-12 Impact factor: 5.027